Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04552990 · ClinicalTrials.gov registry record · Phase 2
Use of Jet-injection in Photodynamic Therapy for Basal Cell Carcinoma
A Phase 2 study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 16
- Enrollment target
NCT04552990: Completed Phase 2 study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT04552990 is a Phase 2 study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04552990, a Phase 2 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 16 participants
- Enrollment target
Study Summary
The purpose of this study is to find out whether injecting ALA into the skin with a jet-injection device and activating the drug with light is a safe treatment that causes few or mild side effects in people with basal cell carcinoma.
Interventions
- PROCEDURE Surgical excision
- DRUG Jet injection of ALA
- PROCEDURE Illumination
- OTHER Incubation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2020-09-09 |
| Est. Completion | 2025-04-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04552990
The ClinicalTrials.gov registry entry for NCT04552990 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Surgical excision is the first listed.
NCT04552990 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04552990 about?
NCT04552990 is a clinical study titled "Use of Jet-injection in Photodynamic Therapy for Basal Cell Carcinoma". The purpose of this study is to find out whether injecting ALA into the skin with a jet-injection device and activating the drug with light is a safe treatment that causes few or mild side effects in people with basal cell carcinoma.
What is the current status of trial NCT04552990?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 16 participants. The study started on 2020-09-09. Estimated completion is 2025-04-04.
What interventions are being tested in trial NCT04552990?
The interventions under investigation include: Surgical excision (PROCEDURE), Jet injection of ALA (DRUG), Illumination (PROCEDURE), Incubation (OTHER).
Who is sponsoring clinical trial NCT04552990?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.